Piccina Cintia

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
4
Insider Sells Sum
$89,825.04

Insider Activity of Piccina Cintia

According to the SEC Form 4 filings, Piccina Cintia, being in a position of

  1. Chief Commercial Officer at Adaptimmune Therapeutics plc,
    оver the last 12 months, has bought 0 shares, and sold 37522 shares for $30,281,
    over all time since 2022-08-01, has bought 0 shares, and sold 70452 shares for $89,825.

The largest sale of all time was on 2022-08-01 and amounted to 21040 shares of Adaptimmune Therapeutics plc for $37,314.

Biography of Piccina Cintia

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$30,2812100

Comparison of Insiders on Amount of Buys and Sells

2025-01-15SaleAdaptimmune Therapeutics plc
ADAP
Chief Commercial Officer
12,991
0.0048%
$0.57$7,467-5.57%
2024-06-18SaleAdaptimmune Therapeutics plc
ADAP
Chief Commercial Officer
24,531
0.0086%
$0.93$22,814-9.11%
2023-01-31SaleAdaptimmune Therapeutics plc
ADAP
Chief Commercial Officer
11,890
0.0072%
$1.87$22,230-51.87%
2022-08-01SaleAdaptimmune Therapeutics plc
ADAP
Chief Commercial Officer
21,040
0.0131%
$1.77$37,314-20.69%
Total: 4
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.